0.028378
0.000000
0.000000
0.000000
0.028378
0.000000
0.000000
0.000000
0.009556
0.00000
0.00000
0.00000
Yadav, M.K.
Leman, L.J.
Stout, C.D.
Ghadiri, M.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
35.238
35.238
104.647
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
45
4463
10.1021/BI060092Q
16584182
Coiled Coils at the Edge of Configurational Heterogeneity. Structural Analyses of Parallel and Antiparallel Homotetrameric Coiled Coils Reveal Configurational Sensitivity to a Single Solvent-Exposed Amino Acid Substitution.
2006
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
93.0
1
2004-06-26
NI FILTER
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RU200
PEPTIDE IS CAPPED WITH PARA ACETAMIDO BENZOIC ACID.
3995.802
GENERAL CONTROL PROTEIN GCN4
YES
2
syn
polymer
AMINO ACID BIOSYNTHESIS REGULATORY PROTEIN, PLI E20C Y17H
no
no
RMKQIEDKLEEILSKLHHICNELARIKKLLGER
RMKQIEDKLEEILSKLHHICNELARIKKLLGER
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
2
38.9
VAPOR DIFFUSION, HANGING DROP
10.50
HANGING DROP, 1UL OF 1MG/ML PEPTIDE IN WATER, 1UL 100MM CAPS, 30% PEG 400, PH 10.5.
database_PDB_rev
database_PDB_rev_record
exptl_crystal_grow
pdbx_database_proc
pdbx_database_status
repository
Initial release
Version format compliance
Version format compliance
Data collection
Experimental preparation
Other
1
0
2004-09-24
1
1
2011-05-08
1
2
2011-07-13
1
3
2019-05-08
_exptl_crystal_grow.method
_pdbx_database_status.recvd_author_approval
HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER
GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID
ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41
THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B)
CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET
GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B
COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION
GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION
GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION
GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION
CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION
PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS
CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA
VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD
CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE
TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES
CRYSTAL STRUCTURE OF B562RIL, A REDESIGNED FOUR HELIX BUNDLE
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
AN ANTI-PARALLEL FOUR HELIX BUNDLE MUTANT PLI-E20C
GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE
LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES)
GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID
GCN4 LEUCINE ZIPPER
AN ANTI-PARALLEL FOUR HELIX BUNDLE.
ABA DOES NOT AFFECT TOPOLOGY OF PLI.
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL TO PARALLEL SWITCH.
PDBE
Y
PDBE
2004-08-06
REL
4932
BAKER'S YEAST
SACCHAROMYCES CEREVISIAE
sample
CHAIN A, B ENGINEERED MUTATION TYR 265 HIS, GLU 268 CYS
THE N-TERMINUS OF THIS PEPTIDE IS CAPPED WITH ABA. DATA
EXHIBITED SOME EPITAXIAL TWINNING, SLIGHTLY HIGH RFREE.
n
1
1
A
MET
2
n
2
MET
2
A
LYS
3
n
3
LYS
3
A
GLN
4
n
4
GLN
4
A
ILE
5
n
5
ILE
5
A
GLU
6
n
6
GLU
6
A
ASP
7
n
7
ASP
7
A
LYS
8
n
8
LYS
8
A
LEU
9
n
9
LEU
9
A
GLU
10
n
10
GLU
10
A
GLU
11
n
11
GLU
11
A
ILE
12
n
12
ILE
12
A
LEU
13
n
13
LEU
13
A
SER
14
n
14
SER
14
A
LYS
15
n
15
LYS
15
A
LEU
16
n
16
LEU
16
A
HIS
17
n
17
HIS
17
A
HIS
18
n
18
HIS
18
A
ILE
19
n
19
ILE
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
GLU
22
n
22
GLU
22
A
LEU
23
n
23
LEU
23
A
ALA
24
n
24
ALA
24
A
ARG
25
n
25
ARG
25
A
ILE
26
n
26
ILE
26
A
LYS
27
n
27
LYS
27
A
LYS
28
n
28
LYS
28
A
LEU
29
n
29
LEU
29
A
LEU
30
n
30
LEU
30
A
GLY
31
n
31
GLY
31
A
GLU
32
n
32
GLU
32
A
n
33
33
A
n
1
1
B
MET
2
n
2
MET
2
B
LYS
3
n
3
LYS
3
B
GLN
4
n
4
GLN
4
B
ILE
5
n
5
ILE
5
B
GLU
6
n
6
GLU
6
B
ASP
7
n
7
ASP
7
B
LYS
8
n
8
LYS
8
B
LEU
9
n
9
LEU
9
B
GLU
10
n
10
GLU
10
B
GLU
11
n
11
GLU
11
B
ILE
12
n
12
ILE
12
B
LEU
13
n
13
LEU
13
B
SER
14
n
14
SER
14
B
LYS
15
n
15
LYS
15
B
LEU
16
n
16
LEU
16
B
HIS
17
n
17
HIS
17
B
HIS
18
n
18
HIS
18
B
ILE
19
n
19
ILE
19
B
CYS
20
n
20
CYS
20
B
ASN
21
n
21
ASN
21
B
GLU
22
n
22
GLU
22
B
LEU
23
n
23
LEU
23
B
ALA
24
n
24
ALA
24
B
ARG
25
n
25
ARG
25
B
ILE
26
n
26
ILE
26
B
LYS
27
n
27
LYS
27
B
LYS
28
n
28
LYS
28
B
LEU
29
n
29
LEU
29
B
LEU
30
n
30
LEU
30
B
GLY
31
n
31
GLY
31
B
GLU
32
n
32
GLU
32
B
n
33
33
B
author_and_software_defined_assembly
PQS
4
tetrameric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_765
-x+2,-y+1,z
crystal symmetry operation
70.4760000000
35.2380000000
0.0000000000
1
A
CD
LYS
3
A
CD
LYS
3
1
Y
1
A
CE
LYS
3
A
CE
LYS
3
1
Y
1
A
NZ
LYS
3
A
NZ
LYS
3
1
Y
1
A
CB
GLN
4
A
CB
GLN
4
1
Y
1
A
CG
GLN
4
A
CG
GLN
4
1
Y
1
A
CD
GLN
4
A
CD
GLN
4
1
Y
1
A
OE1
GLN
4
A
OE1
GLN
4
1
Y
1
A
NE2
GLN
4
A
NE2
GLN
4
1
Y
1
A
CG
ASP
7
A
CG
ASP
7
1
Y
1
A
OD1
ASP
7
A
OD1
ASP
7
1
Y
1
A
OD2
ASP
7
A
OD2
ASP
7
1
Y
1
A
CE
LYS
8
A
CE
LYS
8
1
Y
1
A
NZ
LYS
8
A
NZ
LYS
8
1
Y
1
A
CD
GLU
10
A
CD
GLU
10
1
Y
1
A
OE1
GLU
10
A
OE1
GLU
10
1
Y
1
A
OE2
GLU
10
A
OE2
GLU
10
1
Y
1
A
CD
GLU
11
A
CD
GLU
11
1
Y
1
A
OE1
GLU
11
A
OE1
GLU
11
1
Y
1
A
OE2
GLU
11
A
OE2
GLU
11
1
Y
1
A
CG
HIS
18
A
CG
HIS
18
1
Y
1
A
ND1
HIS
18
A
ND1
HIS
18
1
Y
1
A
CD2
HIS
18
A
CD2
HIS
18
1
Y
1
A
CE1
HIS
18
A
CE1
HIS
18
1
Y
1
A
NE2
HIS
18
A
NE2
HIS
18
1
Y
1
A
CD
LYS
28
A
CD
LYS
28
1
Y
1
A
CE
LYS
28
A
CE
LYS
28
1
Y
1
A
NZ
LYS
28
A
NZ
LYS
28
1
Y
1
B
CG
LYS
3
B
CG
LYS
3
1
Y
1
B
CD
LYS
3
B
CD
LYS
3
1
Y
1
B
CE
LYS
3
B
CE
LYS
3
1
Y
1
B
NZ
LYS
3
B
NZ
LYS
3
1
Y
1
B
CG
GLN
4
B
CG
GLN
4
1
Y
1
B
CD
GLN
4
B
CD
GLN
4
1
Y
1
B
OE1
GLN
4
B
OE1
GLN
4
1
Y
1
B
NE2
GLN
4
B
NE2
GLN
4
1
Y
1
B
CD
GLU
6
B
CD
GLU
6
1
Y
1
B
OE1
GLU
6
B
OE1
GLU
6
1
Y
1
B
OE2
GLU
6
B
OE2
GLU
6
1
Y
1
B
CE
LYS
8
B
CE
LYS
8
1
Y
1
B
NZ
LYS
8
B
NZ
LYS
8
1
Y
1
B
CD
GLU
10
B
CD
GLU
10
1
Y
1
B
OE1
GLU
10
B
OE1
GLU
10
1
Y
1
B
OE2
GLU
10
B
OE2
GLU
10
1
Y
1
B
CD
GLU
11
B
CD
GLU
11
1
Y
1
B
OE1
GLU
11
B
OE1
GLU
11
1
Y
1
B
OE2
GLU
11
B
OE2
GLU
11
1
Y
1
B
CE
LYS
15
B
CE
LYS
15
1
Y
1
B
NZ
LYS
15
B
NZ
LYS
15
1
Y
1
B
CD
ARG
25
B
CD
ARG
25
1
Y
1
B
NE
ARG
25
B
NE
ARG
25
1
Y
1
B
CZ
ARG
25
B
CZ
ARG
25
1
Y
1
B
NH1
ARG
25
B
NH1
ARG
25
1
Y
1
B
NH2
ARG
25
B
NH2
ARG
25
1
Y
1
B
CD
LYS
28
B
CD
LYS
28
1
Y
1
B
CE
LYS
28
B
CE
LYS
28
1
Y
1
B
NZ
LYS
28
B
NZ
LYS
28
1
Y
1
B
CG
GLU
32
B
CG
GLU
32
1
Y
1
B
CD
GLU
32
B
CD
GLU
32
1
Y
1
B
OE1
GLU
32
B
OE1
GLU
32
1
Y
1
B
OE2
GLU
32
B
OE2
GLU
32
1
Y
1
A
ARG
1
A
ARG
1
1
Y
1
A
ARG
33
A
ARG
33
1
Y
1
B
ARG
1
B
ARG
1
1
Y
1
B
ARG
33
B
ARG
33
1
Y
1
16.87
2.70
111.00
127.87
A
A
A
N
CA
C
MET
MET
MET
2
2
2
N
1
13.03
1.80
110.60
123.63
A
A
A
N
CA
CB
HIS
HIS
HIS
18
18
18
N
1
-3.85
0.50
120.30
116.45
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
25
25
25
N
1
-22.44
2.30
111.70
89.26
A
A
A
CD
CE
NZ
LYS
LYS
LYS
27
27
27
N
1
-14.41
2.30
115.30
100.89
A
A
A
CA
CB
CG
LEU
LEU
LEU
30
30
30
N
1
11.60
0.90
118.30
129.90
B
B
B
CB
CG
OD1
ASP
ASP
ASP
7
7
7
N
1
-6.39
0.90
118.30
111.91
B
B
B
CB
CG
OD2
ASP
ASP
ASP
7
7
7
N
1
-9.74
1.60
122.70
112.96
B
B
B
O
C
N
GLU
GLU
GLU
10
10
11
Y
1
-10.42
1.20
123.30
112.88
B
B
B
OE1
CD
OE2
GLU
GLU
GLU
22
22
22
N
1
A
A
CA
CB
LEU
LEU
16
16
-0.150
0.023
1.533
1.383
N
1
A
A
C
O
HIS
HIS
17
17
-0.117
0.019
1.229
1.112
N
1
A
A
CD
OE1
GLU
GLU
22
22
0.141
0.011
1.252
1.393
N
1
B
B
C
O
CYS
CYS
20
20
0.118
0.019
1.229
1.347
N
1
B
B
CB
CG
ASN
ASN
21
21
0.162
0.023
1.506
1.668
N
1
B
B
C
O
GLY
GLY
31
31
0.099
0.016
1.232
1.331
N
1
A
LEU
30
-35.23
-30.26
0.914
0.873
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. N TERMINUS IS CAPPED WITH ABA.
0.344
0.280
0.282
2.50
35.41
116
2517
4.400
100.0
RANDOM
1
THROUGHOUT
2.000
MOLECULAR REPLACEMENT
0.563
0.369
0.80
0.80
1.40
MAXIMUM LIKELIHOOD
BABINET MODEL WITH MASK
2.50
35.41
0
450
0
0
450
0.3040
0.3000
2.57
8
177
20
2.200
35.410
1W5H
3786
2.000
0.05000
1
17.2000
7.060
100.0
0.36000
2.20
2.28
4.700
1
7.11
100.0
refinement
REFMAC
5.1.24
data reduction
CrystalClear
(MSC/RIGAKU)
data scaling
CrystalClear
(MSC/RIGAKU)
phasing
MOLREP
GENERAL CONTROL PROTEIN GCN4
An anti-parallel four helix bundle.
1
N
N
1
N
N
A
MET
2
A
MET
2
HELX_P
A
GLU
32
A
GLU
32
1
1
31
B
MET
2
B
MET
2
HELX_P
B
GLY
31
B
GLY
31
1
2
30
FOUR HELIX BUNDLE
FOUR HELIX BUNDLE, ANTIPARALLEL FOUR HELIX BUNDLE
GCN4_YEAST
UNP
1
P03069
249
281
1W5H
1
33
P03069
A
1
1
33
249
281
1W5H
1
33
P03069
B
1
1
33
1
LEU
conflict
ILE
5
1W5H
A
P03069
UNP
253
5
1
VAL
conflict
LEU
9
1W5H
A
P03069
UNP
257
9
1
LEU
conflict
ILE
12
1W5H
A
P03069
UNP
260
12
1
ASN
conflict
LEU
16
1W5H
A
P03069
UNP
264
16
1
TYR
engineered mutation
HIS
17
1W5H
A
P03069
UNP
265
17
1
LEU
conflict
ILE
19
1W5H
A
P03069
UNP
267
19
1
GLU
engineered mutation
CYS
20
1W5H
A
P03069
UNP
268
20
1
VAL
conflict
LEU
23
1W5H
A
P03069
UNP
271
23
1
LEU
conflict
ILE
26
1W5H
A
P03069
UNP
274
26
1
VAL
conflict
LEU
30
1W5H
A
P03069
UNP
278
30
2
LEU
conflict
ILE
5
1W5H
B
P03069
UNP
253
5
2
VAL
conflict
LEU
9
1W5H
B
P03069
UNP
257
9
2
LEU
conflict
ILE
12
1W5H
B
P03069
UNP
260
12
2
ASN
conflict
LEU
16
1W5H
B
P03069
UNP
264
16
2
TYR
engineered mutation
HIS
17
1W5H
B
P03069
UNP
265
17
2
LEU
conflict
ILE
19
1W5H
B
P03069
UNP
267
19
2
GLU
engineered mutation
CYS
20
1W5H
B
P03069
UNP
268
20
2
VAL
conflict
LEU
23
1W5H
B
P03069
UNP
271
23
2
LEU
conflict
ILE
26
1W5H
B
P03069
UNP
274
26
2
VAL
conflict
LEU
30
1W5H
B
P03069
UNP
278
30
94
P 42 21 2